Marin Vulić

3.7k total citations · 1 hit paper
22 papers, 2.8k citations indexed

About

Marin Vulić is a scholar working on Genetics, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Marin Vulić has authored 22 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 14 papers in Molecular Biology and 5 papers in Infectious Diseases. Recurrent topics in Marin Vulić's work include Bacterial Genetics and Biotechnology (12 papers), DNA Repair Mechanisms (6 papers) and Antibiotic Resistance in Bacteria (5 papers). Marin Vulić is often cited by papers focused on Bacterial Genetics and Biotechnology (12 papers), DNA Repair Mechanisms (6 papers) and Antibiotic Resistance in Bacteria (5 papers). Marin Vulić collaborates with scholars based in United States, France and Germany. Marin Vulić's co-authors include Kim Lewis, Tobias Dörr, Miroslav Radman, Sonja Hansen, François Taddéi, Roberto Kolter, Francisco Dionísio, Amy L. Spoering, Iris Keren and Yanxia Wu and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Marin Vulić

22 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ciprofloxacin Causes Persister Formation by Inducing the TisB toxin in Escherichia coli

2010 586 citations Tobias Dörr, Marin Vulić et al. PLoS Biology profile →

Peers

Countries citing papers authored by Marin Vulić

Since Specialization

Citations

This map shows the geographic impact of Marin Vulić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marin Vulić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marin Vulić more than expected).

Fields of papers citing papers by Marin Vulić

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marin Vulić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marin Vulić. The network helps show where Marin Vulić may publish in the future.

Co-authorship network of co-authors of Marin Vulić

This figure shows the co-authorship network connecting the top 25 collaborators of Marin Vulić. A scholar is included among the top collaborators of Marin Vulić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marin Vulić. Marin Vulić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	110: IMPACT OF SER-109, AN INVESTIGATIONAL MICROBIOME THERAPEUTIC, ON STOOL FATTY ACID METABOLITES IN A PHASE 3 RANDOMIZED TRIAL (ECOSPOR III) FOR TREATMENT OF RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION (CDI) 2022 ·Gastroenterology ·Jessica A. Bryant, Marin Vulić, Christopher DesJardins, Christopher B. Ford, (unknown), Jennifer R. Wortman, Matthew R. Henn	1
2	130. Design and Preclinical Characterization of SER-155, an Investigational Cultivated Microbiome Therapeutic to Restore Colonization Resistance and Prevent Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation 2021 ·Open Forum Infectious Diseases ·(unknown), Marin Vulić, Edward J. O’Brien, (unknown), Mary‐Jane Lombardo, Christopher B. Ford, (unknown)	1
3	681 SER-301, AN INVESTIGATIONAL, RATIONALLY-DESIGNED BACTERIAL CONSORTIUM FOR MILD-TO-MODERATE ULCERATIVE COLITIS, RECAPITULATES THE EFFECTS OF SER-287, A CONSORTIUM OF FIRMICUTE SPORES, ON REMISSION ASSOCIATED MICROBIAL METABOLITES AND HOST GENE EXPRESSION 2021 ·Gastroenterology ·Asunción Martínez Martínez, Edward J. O’Brien, Divya Balasubramanian, Meghan Chafee, (unknown), (unknown), Karen J. Kieser, Marin Vulić, (unknown), Brian Weiner, Christopher B. Ford, Jennifer R. Wortman, Matthew R. Henn	1
4	A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents RecurrentClostridium difficileInfection 2016 ·The Journal of Infectious Diseases ·Sahil Khanna, Darrell S. Pardi, Colleen Kelly, Colleen S. Kraft, Tanvi Dhere, Matthew R. Henn, Mary-Jane Lombardo, Marin Vulić, Toshiro K. Ohsumi, Jonathan Winkler, Christina Pindar, Barbara McGovern, Roger J. Pomerantz, John Auniņš, David N. Cook, Elizabeth Hohmann	230
5	HipBA–promoter structures reveal the basis of heritable multidrug tolerance 2015 ·Nature ·Maria A. Schumacher, (unknown), Jungki Min, Naga Babu Chinnam, Sonja Hansen, Marin Vulić, Kim Lewis, Richard G. Brennan	174
6	Tolerance ofEscherichia colito Fluoroquinolone Antibiotics Depends on Specific Components of the SOS Response Pathway 2013 ·Genetics ·(unknown), Kim Lewis, Marin Vulić	69
7	Regulation of the Escherichia coli HipBA Toxin-Antitoxin System by Proteolysis 2012 ·PLoS ONE ·Sonja Hansen, Marin Vulić, Jungki Min, Tien-Jui Yen, Maria A. Schumacher, Richard G. Brennan, Kim Lewis	76
8	Role of Oxidative Stress in Persister Tolerance 2012 ·Antimicrobial Agents and Chemotherapy ·Yanxia Wu, Marin Vulić, Iris Keren, Kim Lewis	209
9	Population Dynamics of Escherichia coli in Surface Water1 2011 ·JAWRA Journal of the American Water Resources Association ·Vanni Bucci, Marin Vulić, (unknown), Ferdi L. Hellweger	15
10	Ciprofloxacin Causes Persister Formation by Inducing the TisB toxin in Escherichia coli breakdown → 2010 ·PLoS Biology ·Tobias Dörr, Marin Vulić, Kim Lewis	586
11	SOS Response Induces Persistence to Fluoroquinolones in Escherichia coli 2009 ·PLoS Genetics ·Tobias Dörr, Kim Lewis, Marin Vulić	384
12	Direct Visualization of Horizontal Gene Transfer 2008 ·Science ·Ana Babić, Ariel B. Lindner, Marin Vulić, Eric J. Stewart, Miroslav Radman	162
13	Role of Global Regulators and Nucleotide Metabolism in Antibiotic Tolerance in Escherichia coli 2008 ·Antimicrobial Agents and Chemotherapy ·Sonja Hansen, Kim Lewis, Marin Vulić	227
14	GlpD and PlsB Participate in Persister Cell Formation in Escherichia coli 2006 ·Journal of Bacteriology ·Amy L. Spoering, Marin Vulić, Kim Lewis	168
15	Alcohol-Induced Delay of Viability Loss in Stationary-Phase Cultures of Escherichia coli 2002 ·Journal of Bacteriology ·Marin Vulić, Roberto Kolter	26
16	Mutation, recombination, and incipient speciation of bacteria in the laboratory 1999 ·Proceedings of the National Academy of Sciences ·Marin Vulić, Richard E. Lenski, Miroslav Radman	63
17	Genetic variability and adaptation to stress 1997 ·Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions ·François Taddéi, Marin Vulić, Miroslav Radman, Ivan Matić	38
18	Molecular keys to speciation: DNA polymorphism and the control of genetic exchange in enterobacteria 1997 ·Proceedings of the National Academy of Sciences ·Marin Vulić, Francisco Dionísio, François Taddéi, Miroslav Radman	229
19	Die Reaktionen verschiedener Pflanzenarten auf Blattinfektionen mit S‐ und M‐Virus der Kartoffel 1967 ·Journal of Phytopathology ·Marin Vulić, (unknown)	14
20	Zur „Immunität“ der Sorte Saco gegenüber dem S-Virus der Kartoffel 1967 ·Der Züchter ·Marin Vulić, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact